[go: up one dir, main page]

UA93017U - Препарат "нановулин-врх" - Google Patents

Препарат "нановулин-врх"

Info

Publication number
UA93017U
UA93017U UAU201404615U UAU201404615U UA93017U UA 93017 U UA93017 U UA 93017U UA U201404615 U UAU201404615 U UA U201404615U UA U201404615 U UAU201404615 U UA U201404615U UA 93017 U UA93017 U UA 93017U
Authority
UA
Ukraine
Prior art keywords
nanovulin
bpx
medication
aquakhelate
observed
Prior art date
Application number
UAU201404615U
Other languages
English (en)
Ukrainian (uk)
Inventor
Виктор Иванович Шеремета
Original Assignee
Национальный Университет Биоресурсов И Природопользования Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Университет Биоресурсов И Природопользования Украины filed Critical Национальный Университет Биоресурсов И Природопользования Украины
Priority to UAU201404615U priority Critical patent/UA93017U/ru
Publication of UA93017U publication Critical patent/UA93017U/ru

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Препарат "Нановулин-ВРХ" содержит сукцинат натрия та натрия глутаминат. Дополнительно содержит аквахелат меди, и используется при следующем соотношении ингредиентов, %:
UAU201404615U 2014-04-29 2014-04-29 Препарат "нановулин-врх" UA93017U (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201404615U UA93017U (ru) 2014-04-29 2014-04-29 Препарат "нановулин-врх"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201404615U UA93017U (ru) 2014-04-29 2014-04-29 Препарат "нановулин-врх"

Publications (1)

Publication Number Publication Date
UA93017U true UA93017U (ru) 2014-09-10

Family

ID=56281705

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201404615U UA93017U (ru) 2014-04-29 2014-04-29 Препарат "нановулин-врх"

Country Status (1)

Country Link
UA (1) UA93017U (ru)

Similar Documents

Publication Publication Date Title
MX393936B (es) Combinacion de elafibranor o derivados del mismo con un agente anti-ehna, antifibrotico o anticolestasico
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
SG10201803042PA (en) Anti-tim-3 antibodies
AU366476S (en) Bottle
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
MY187540A (en) Compounds active towards bromodomains
MY191581A (en) Anti-pd-1 antibodies
SG10201808151RA (en) Cortistatin analogues and syntheses and uses thereof
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
AU365587S (en) Kettle
MY193650A (en) Extracellular matrix compositions
TWD165710S (zh) 電連接器
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
ZA201803476B (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2017007577A (es) Compuestos de dihidropirimidin-2-ona y su uso medico.
MX2020002585A (es) Inhibidor de hdac combinado con un modulador del punto de control inmunitario para la terapia contra el cancer.
MY178960A (en) Hiv treatment formulation of atazanavir and cobicistat
PH12016501838A1 (en) Compounds and their methods of use
MX2015016603A (es) Composiciones de corticosteroides.